Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Millendo Therapeutics Inc (MLND)
Millendo Therapeutics Inc (MLND) Financials

MLND Millendo Therapeutics Inc

1.06

0.00 (0.00%)

May 30 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Return on Assets (%)	-62.997	-52.176	-34.656	-56.045	-61.508	-48.526	-59.851	-60.375
Return on Equity (%)	-69.988	-59.096	-39.575	-67.023	-77.793	-81.045	-131.699	-131.424
Return on Invested Capital (%)	-70.7	-59.953	-39.465	-68.586	-77.386	-63.864	-87.554	-96.169
Operating Margin (%)	-12566.462	-17256.949	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	-12597.243	-17279.661	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	3.036	1.8	5.474	3.278	1.775	5.227	1.722	1.391
Earnings Per Share	-2.308	-1.427	-2.036	-2.44	-1.916	-4.096	-3.395	-1.532
Cash Per Share	1.233	0.44	5.486	3.42	2.009	7.501	2.969	2.038
Working Capital Per Share	2.897	1.707	5.51	3.209	1.732	7.082	2.441	1.608
Operating Profit Per Share	-0.07	-0.014	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-2.302	-1.425	-2.035	-2.44	-1.916	-4.096	-3.395	-1.532
EBITDA Per Share	-2.302	-1.425	-2.035	-2.44	-1.916	-4.096	-3.395	-1.532
Free Cash Flow Per Share	-2.298	-1.469	-2.033	-2.423	-1.923	-4.13	-3.402	-1.543

Liquidity Ratios

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	8.816	8.814	8.498	5.681	5.121	3.444	4.528	4.289
Quick Ratio	8.66	8.611	7.916	5.073	4.84	2.588	4.292	4.169
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	35.64M	35.73M	13.36M	18.27M	19M	6.91M	10.52M	N/A

Key Stats and Ratios

Year End December 30 2023	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Shares Outstanding	7.17M	10.33M	10.52M	10.52M	11.59M	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	3.013	N/A	N/A	N/A	3.285	N/A	N/A	N/A
Quick Ratio	2.198	N/A	N/A	N/A	3.052	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	64.28M
Price to Earnings Ratio	-2.18
Price to Sales Ratio	0
Price to Cash Ratio	1.64
Price to Book Ratio	2.4
Dividend Yield	-

Share Statistics

Shares Outstanding	19.25M
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-
52 Week High	-
52 Week Low	-

More Ratios Coming Soon!

Millendo Therapeutics

Delayed Upgrade Clock